COMMUNIQUÉS West-GlobeNewswire

Summit Therapeutics plc : Exercise of Options
05/10/2017
Summit Therapeutics plc ("Summit" or the "Company") EXERCISE OF SHARE OPTIONS Oxford, UK, 5 October 2017 - Summit Therapeutics plc (AIM: SUMM, NASDAQ: SMMT), the drug discovery and development company advancing [...]
Final result of the voluntary offer for Weifa ASA
05/10/2017
Following final registration of acceptances, the final acceptance level in Karo Pharma AB's ("Karo Pharma") voluntary offer ("Voluntary Offer") to acquire all shares in Weifa ASA ("Weifa") is 35,463,139 shares [...]
Terveystalo Plc announces the early close of the Public Offering and the Personnel Offering due to oversubscription
05/10/2017
TERVEYSTALO PLC STOCK EXCHANGE RELEASE October 5, 2017 at 4:00 pm NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, THE HONG KONG SPECIAL [...]
Shire plc : Director/PDMR Shareholding
05/10/2017
Director/PDMR Shareholding October 5, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") Notification of transactions by person discharging managerial responsibilities 1. Details of the person discharging [...]
Orion receives Lean Prize 2016
05/10/2017
ORION CORPORATION PRESS RELEASE 5 OCT 2017 at 12:35 EEST Orion receives Lean Prize 2016 As the cost pressures on pharmaceutical companies increase, Orion needs to constantly improve its efficiency to stay competitive. [...]
DRGT announces results of Phase I study expanding clinical utility of the drug Sirolimus utilizing the company's novel Super-API technology platform
05/10/2017
MSIDA, Malta, Oct. 05, 2017 (GLOBE NEWSWIRE) -- DRGT, a specialty pharmaceutical company, today announced the results of its Phase I study of DRGT18-2, a novel formulation of Sirolimus (Rapamune®), originally a Pfizer [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
05/10/2017
FIT Biotech Oy Company release October 5, 2017 at 10:00 AM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]
Solon Eiendom ASA : Primary insider notification
05/10/2017
(Oslo, Norway, 4 October 2017) Solon Eiendom ASA Board Member Tore Aksel Voldberg (through his wholly owned company Skøien AS) has today bought 1 000 shares in Solon Eiendom ASA at a price of NOK 18,5000. Following this [...]
FIT Biotech Oy: FIT Biotech initiates gene therapy research collaboration with Avacta
05/10/2017
FIT Biotech Oy Company release 05.10.2017 at 9.00 EET FIT Biotech initiates gene therapy research collaboration with Avacta FIT Biotech Oy ("Company") today announced that it has initiated a research collaboration with [...]
MDxHealth Opens New Service and Research Laboratory in The Netherlands
05/10/2017
COMPANY ANNOUNCEMENT HERSTAL, BELGIUM - 07:00 CEST, October 5, 2017 - MDxHealth SA (Euronext: MDXH.BR) today announced the opening of its new service and research laboratory at the Novio Tech Campus in Nijmegen, the [...]
MDxHealth ouvre un nouveau laboratoire de service et de recherche aux Pays-Bas
05/10/2017
Annonce d'entreprise HERSTAL, BELGIQUE - 07:00 CEST, 5 octobre 2017 - MDxHealth SA (Euronext: MDXH.BR) a annoncé l'ouverture de son nouveau laboratoire de service et de recherche, au Novio Tech Campus de Nimègue, aux [...]
TiGenix to present positive 52-week Phase III results of Cx601 at World Congress of Gastroenterology at ACG 2017 meeting
05/10/2017
PRESS RELEASE TiGenix to present positive 52-week Phase III results of Cx601 at World Congress of Gastroenterology at ACG 2017 meeting Leuven (BELGIUM) - October 5, 2017, 07:00h CET - TiGenix NV (Euronext Brussels and [...]
TiGenix présentera les résultats favorables de la semaine 52 de l'essai de phase III de Cx601 à l'occasion du Congrès Mondial de Gastro-entérologie à ACG 2017
05/10/2017
COMMUNIQUÉ DE PRESSE TiGenix présentera les résultats favorables de la semaine 52 de l'essai de phase III de Cx601 à l'occasion du Congrès Mondial de Gastro-entérologie à ACG 2017 Louvain (BELGIQUE) - 5 octobre 2017, [...]
PCI Biotech receives US Orphan Drug Designation for fimaporfin in the treatment of bile duct cancer (cholangiocarcinoma)
04/10/2017
Oslo, 4 October 2017 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its lead product [...]
Abeona Therapeutics Announces Dedication of Commercial Gene Therapy Manufacturing Facility in Cleveland, Ohio
04/10/2017
-- Facility to support development of advanced gene and cell therapies for treatment of life-threatening rare diseases -- Leaders from local government, life sciences and medical technology to join on October 4 for [...]
EDAP Announces FDA Clearance of its Ablatherm-Fusion® device
04/10/2017
LYON, France, October 4, 2017 -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced FDA approval of its Ablatherm-Fusion device enabling a more precise method for targeting of [...]
Immunocore Appoints Andrew Hotchkiss as Chief Commercial Officer
04/10/2017
PRESS RELEASE Immunocore Appoints Andrew Hotchkiss as Chief Commercial Officer (Oxford, UK and Conshohocken, US, 4 October 2017) Immunocore Limited, the world's leading TCR company developing biological drugs to treat [...]
Summit Highlights DMD Biomarker Validation Data at 22nd WMS Congress
04/10/2017
Summit Therapeutics plc ('Summit', or 'the Company') SUMMIT HIGHLIGHTS DMD BIOMARKER VALIDATION DATA AND PHASE 2 CLINICAL TRIAL BASELINE CHARACTERISTICS IN PRESENTATIONS AT 22ND WMS CONGRESS Oxford, UK, 4 October 2017 [...]
Zealand Pharma and Torrey Pines Institute for Molecular Studies announce research collaboration
04/10/2017
Press release - No. 8/2017 Zealand Pharma and Torrey Pines Institute for Molecular Studies announce research collaboration Combining expertise in discovery and development of peptide therapeutics with unique peptide [...]

Pages